D-0374-2022 Class II Terminated
FDA drug recall D-0374-2022 was initiated by Ingenus Pharmaceuticals Llc on Jan 10, 2022 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Aug 15, 2023). Affected quantity: 45,173 cans.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 26, 2022
- Initiation Date
- Jan 10, 2022
- Termination Date
- Aug 15, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 45,173 cans
Product description
Clobetasol Propionate Foam, 0.05%, packaged in a) 50 g can (NDC 50742-304-50), and b) 100 g can (NDC 50742-304-01), Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC, Orlando, FL 32839-6408.
Reason for recall
CGMP Deviations
Distribution pattern
Nationwide in the USA
Code information
a) Lots: 32921 Exp. 06/2022; 33152 Exp. 08/2022; 33340 Exp. 11/2022; b) Lots: 33152 Exp. 08/2022; 33340 Exp. 11/2022.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0374-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026